Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 3, 2005, Pages 487-496

  Gasparetto, C ^a   Malinverno, A ^b   Culacciati, D ^b   Gritti, D ^b   Prosperini, P G ^c   Specchia, G ^c   Ricevuti, Giovanni ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Policlinico of Monza   (Italy)

Author keywords

Acute myocardial infarction; Antioxidant vitamins; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; PLACEBO; REACTIVE OXYGEN METABOLITE; RETINOL; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

EID: 27444441151     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800308     Document Type: Article

References (43)

1. Grech E.D. and D.R. Ramsdale. 2003. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. Br. Med. J. 326:1259.
2. Das U.N. 2000. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol. Cell. Biochem. 215:145.
3. Ricevuti G., S. De Servi, A. Mazzone, L. Angoli, S. Ghio and G. Specchia. 1990. Increased neutrophil aggregability in coronary artery disease. Eur. Heart J. 11:814.
4. De Servi S., G. Ricevuti, A. Mazzone, D. Pasotti, E. Bramucci, L. Angoli and G. Specchia. 1991. Transcardiac release of leukotriene C4 by neutrophils in patients with coronary artery disease. J. Am. Coll. Cardiology 17:1125.
5. Notario A. and G. Ricevuti. 1992. Cytokines in internal medicine: physiopathology, clinical aspects and therapeutic implications. Int. J. Immunopathol. Pharmacol. 5:67.
6. Ricevuti G. 1997. Host tissue damage by phagocytes. Phagocytes: biology, physiology, pathology and pharmacotherapeutics. Ann. N. Y. Acad. Sci. 832:426.
7. Hernandez M.R., J. Bozzo, R. Tonda, A.M. Galan, A. Ordinas and G. Escolar. 2001. Effect of anticoagulants on activation of polymorphonuclear leukocytes induced by shear stress. Int. J. Immunopathol. Pharmacol. 14:139.
8. Ricevuti G., A. Mazzone, S. De Servi and P. Fratino. 1989. New trends in coronary artery disease: the role of granulocyte activation. Atherosclerosis 78:261.
9. Ghoneum M. and M. Matsuura. 2004. Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/Biobran). Int. J. Immunopathol. Pharmacol. 17:283.
10. Demidova T.N. and M.R. Hamblin. 2004. Targeted photodynamic therapy to inflammatory cells and pathogens. Int. J. Immunopathol. Pharmacol. 17:117.
11. Babior B.M. 2002. The leukocyte NADPH oxidase. Isr. Med. Assoc. J. 4:1023.
12. Ide T., H. Tsutsui, S. Hayashidani, et al. 2001 Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 88:529
13. Di Napoli R, A.A. Taccardi, A. Grilli, M. Felaco, L. Di Gioacchino, R. De Caterina and A. Barsotti. 2002. Verapamil reduces coronary endothelium damage and cardiomyocyte necrosis but not apoptosis after ischemia and reperfusion: ex-vivo study in rat hearts. Int. J. Immunopathol. Pharmacol. 15:225.
14. Agostini M., B. Di Marco, G. Nocentini and V.D. Delfino. 2002. Oxidative stress and apoptosis in immune diseases. Int. J. Immunopathol. Pharmacol. 15:157.
15. Du J. and J.M. Gebicki. 2002. DNA degradation and protein peroxidation in cells exposed to hydroxyl free radicals. Redox Rep. 7:329.
16. Ricevuti G., A. Mazzone, D. Pasotti, S. De Servi and G. Specchia. 1991. Role of granulocytes in endothelial injury in coronary heart disease in humans. Atherosclerosis 91:1.
17. Mazzone A., S. De Servi, G. Ricevuti, I. Mazzucchelli, G.L. Fossati, D. Pasotti, E. Bramucci, L. Angoli, F. Marsico, G. Specchia and A. Notario. 1993. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88:358.
18. De Servi S., A. Mazzone, G. Ricevuti, G. Fossati, I. Mazzucchelli, G. Fossati, D. Gritti, L. Angoli and G. Specchia. 1995. Clinical and angiographic correlates of leukocyte activation in unstable angina. JACC 26:1146.
19. Gritti D., A. Malinverno, C. Gasparetto, C.J. Wiederman and G. Ricevuti. 2004. Attenuation of leukocyte beta 2-integrin expression by antithrombin-III. Int. J. Immunopathol. Pharmacol. 17:27.
20. Sardella G., D. Accapezzato, A. Di Roma, C. Iacoboni, V. Francavilla, G. Benedetti, C. Musto, F. Fedele, G. Bruno and M. Paroli. 2004. Integrin ?2-chain (CD 18) over-expression on CD4+ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 17:165.
21. De Servi S., A. Mazzone, G. Ricevuti, A. Fioravanti, E. Bramucci, L. Angoli, S. Ghio and G. Specchia. 1990. Granulocyte activation after Coronary angioplasty in human Circulation 82:140.
22. Cuzzocrea S., D.P. Riley, A.P. Caputi and D. Salvemini. 2001. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53:135.
23. Kinugawa H., H. Tsutsui, S. Hayashidani, T. Ide, N. Suematsu and S. Satoh. 2000. Treatment with Dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice. Role of oxidative stress. Circ. Res. 87:392.
24. Padayatty S.J., A. Katz, Y. Wang, P. Eck, O. Kwon, J.H. Lee, S. Chen, C. Corpe, A. Dutta, S.K. Dutta and M. Levine. 2003. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J. Am. Coll. Nutr. 22:18.
25. Blumberg J.B. 2002. An update: vitamin E supplementation and heart disease. Nutr. Clin. Care 5:50.
26. Palace V.P., N. Khaper, Q. Qin and P.K. Singal. 1999. Antioxidant potential of vitamin A and carotenoids and their relevance to heart disease. Free Radic. Biol. Med. 26:746.
27. Willis M.S. and F.H. Wians jr. 2003. The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin. Chim. Acta 330:57.
28. Reifen R. 2002. Vitamin A as an anti-inflammatory agent. Proc. Nutr. Soc. 61:397.
29. Diaz J., E. Serrano, F. Acosta and L.F. Carbonell. 1998. Reference intervals for four biochemistry analytes in plasma for evaluating oxidative stress and lipid peroxidation in human plasma. Clin. Chem. 44:2215.
30. Dahlgren C. and A. Karlsson. 1999. Respiratory burst in human neutrophils. J. Immunol. Methods 232:3.
31. The GUSTO investigation: an international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. 1993. N. Engl. J. Med. 329:373.
32. Cesarone M.R., G. Belcaro, M. Carratelli, U. Cornelli, M.T. De Sanctis and L. Incandela. 1999. A simple test to monitor oxidative stress. Int. Angiol. 18:127.
33. Mantovani G., A. Macciò, C. Madeddu, L. Mura, E. Massa, G. Gramignano, M.L. Lusso, V. Murgia, P. Camboni and L. Ferreli. 2002. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J. Cell. Mol. Med. 6:570.
34. Cornelli U., R. Terranova, S. Luca, M. Cornelli and A. Alberti. 2001. Bioavailability and antioxidant activity of some food supplements in men and women using the d'ROMs test as a marker of oxidative stress. J. Nutr. 131:3208.
35. Singh R.B., M.A. Niaz, S. Ghosh and S.S. Rastogi. 1993. Effect on mortality and reinfarction of adding fruits and vegetables to a prudent diet in the Indian experiment of infarct survival (IEIS). J. Am. Coll. Nutr. 12:255.
36. Hercberg S., P. Galan, P. Preziosi, A.M. Roussel, J. Arnaud, M.J. Richard, D. Malvy, A. Paul-Dauphin, S. Briancon and A. Favier. 1998. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Supplementation en Vitamines et Mineraux AntioXydants Study. Int. J. Vitam. Nutr. Res. 68:3.
37. Stephens N.G., A. Parson, P. Schofield, F. Kelly, K. Cheeseman and M.J. Mitchinson. 1996. Randomised controlled trial of vitamin E in patients with artery coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781.
38. Stampfer M.J., C.H. Hennekens, J.E. Manson, G.A. Colditz, B. Rosner and Willett W.C. 1993. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1444.
39. Yusuf S., G. Dagenais, J. Pogue, J. Bosch, R. Davies and G. Dagenais. 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342:154.
40. Kaneider N.C., A. Kaser , H. Tilg, G. Ricevuti and C.J. Wiedermann. 2003. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol. 16:225
41. Halliwel B., J.M.C. Gutteridge. 1989. Protection against oxidants in biological systems: the superoxide theory of oxigen toxicity. In Free radicals in biology and medicine. Oxford Clarendon Press p.324
42. Pryor W.A. 1994. Free radicals and lipid peroxidation: what they are and how they got that way. In Natural antioxidants in human health and disease. B. Frei, ed. Academic Press Orlando FL, p.443
43. Combs Jr G.F. 1998. The vitamins. In Fundamental aspects in nutrition and disease. Ed. Academic Press San Diego, p. 135